Of note, participants with high serum levels of FGF21 more frequently had metabolic complications, such as hypertension, obesity, diabetes, hypercholesterolemia, and hypertriglyceridemia. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.